Skip to content

Diabetes Outcomes and Unmet Resources

Improving Diabetes Outcomes and Health Disparities Through a Patient Activation Intervention Addressing Unmet Resource Needs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03950973
Enrollment
667
Registered
2019-05-15
Start date
2019-06-26
Completion date
2023-03-28
Last updated
2024-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Diabetes, Self-management, Adherence, Social determinants of health, Social risk factors

Brief summary

This study will refine and test the effectiveness of CareAvenue, an automated e-health tool that informs and activates patients with uncontrolled diabetes to take steps in accessing resources and engaging in self-care. Our central hypothesis is that activating patients with uncontrolled diabetes and linking them to resources to address financial burden and unmet social risk factors will improve both intermediate outcomes and measures of disease control above and beyond existing services, especially for high need patients.

Interventions

BEHAVIORALCareAvenue

CareAvenue is an e-health tool providing information about diabetes management and low-cost resources. Participants in this group have access to CareAvenue and receive a weekly automated phone call and text messages related to CareAvenue and its resources as well as diabetes management.

BEHAVIORALGuest Assistance Program

The Guest Assistance Program (GAP) is a resource, which provides assistance with medical and non-medical needs and resources to patients receiving medical care at University of Michigan health system. Participants in this group are provided with GAP information and receive text messages related to diabetes management.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Be 18-75 years of age * Be diagnosed with type 1 or type 2 diabetes with prescribed anti-hyperglycemic medication * Have a most recent hemoglobin A1c(HbA1c) level within the past 6 months of ≥7.5% for individuals ≤70 years and \>8.0% for individuals between 70-75 years in age * Have access to a telephone that can receive and send text messages * Not participating in another diabetes intervention research study

Exclusion criteria

* Significant cognitive impairment precluding individuals from completing the study as evidenced by ability to complete study intake procedures.

Design outcomes

Primary

MeasureTime frameDescription
Change in HbA1c as Measured by an HbA1c MachineAssessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)HbA1c will be measured at baseline, 6 months, and 12 months using HbA1c machine. HbA1c is a measure of the average level of glucose in blood over the past 3 months measured as a percentage. The change in HbA1c from baseline to 12 months is reported here as the primary outcome.

Secondary

MeasureTime frameDescription
Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Diabetes as Measured by Participant QuestionnaireAssessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)Cost-Related Non-Adherence (CRN) Behaviors related to diabetes will be measured at baseline, 6 months, and 12 months by 4-items adapted from the Medicare Current Beneficiary Survey and 2 items adapted from the National Health Interview Survey that look at diabetes. The items are measured with a 4-point Likert scale. Participants answering often or sometimes to any of the items are indicated as exhibiting CRN. Min value of 0, max value of 18, with higher scores indicating more cost-related non-adherence behaviors. The change in CRN behaviors from baseline to 12 months is reported here as the secondary outcome.
Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Other Conditions Being Managed as Measured by Participant QuestionnaireAssessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)Cost-Related Non-Adherence (CRN) Behaviors related to other conditions being managed will be measured at baseline, 6 months, and 12 months by 4-items adapted from the Medicare Current Beneficiary Survey and 2 items adapted from the National Health Interview Survey that look at other health conditions being managed. The items are measured with a 4-point Likert scale. Participants answering often or sometimes to any of the items are indicated as exhibiting CRN. Mean values were obtained, with min value of 0, max value of 1, with higher mean scores indicating more cost-related non-adherence behaviors. The change in CRN behaviors from baseline to 12 months is reported here as the secondary outcome.
Change in Systolic Blood Pressure as Measured an Automated Blood Pressure MachineAssessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)Systolic blood pressure will be measured at baseline, 6 months, and 12 months using an automated blood pressure machine in millimeters of mercury (e.g., 120 mm Hg). The change in systolic blood pressure from baseline to 12 months is reported here as secondary outcome.
Change in Unmet Social Risk Factors as Measured by 20 Items in Participant QuestionnaireAssessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)Change in Unmet Social Risk Factors will be measured at baseline, 6 months, and 12 months by 20 items adapted from the Accountable Health Communities Health-Related Social Needs Screening Tool, the Health Leads Social Needs Screening Toolkit, and the Kaiser Permanente Your Current Life Situation Questionnaire. The item values are binary (yes/no). Higher number of yes responses indicates higher number of unmet social risk factors/higher need. (Min value of 0, max value of 20). The change in unmet social risk factors from baseline to 12 months is reported here as secondary outcome.
Change in Unmet Social Risk Factors as Measured by Participant QuestionnaireAssessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)Change in Unmet Social Risk Factors will be measured at baseline, 6 months, and 12 months by 3 items from the Accountable Health Communities Health-Related Social Needs Screening Tool and 1 item adapted from the National Health Interview Survey. The items each have three response options, in which a positive response indicates an unmet social risk factor. Higher scores indicate more unmet social risk factors (min value of 0; max value of 8). The change in unmet social risk factors from baseline to 12 months is reported here as secondary outcome.
Change in Perceived Financial Burden as Measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT)Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)Perceived Financial Burden will be measured at baseline, 6 months, and 12 months by the 11-item measure Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT) that were measured on a 5-point scale (0: not at all - 4: very much). The score includes reverse-coding 6-items, summing all items, multiplying sum by 11 and dividing the total by number of items answered. Lower scores indicate higher perceptions of financial burden. (Min value of 0, max value of 44) The change in perceived financial burden (COST measure) from baseline to 12 months is reported here as secondary outcome.

Countries

United States

Participant flow

Pre-assignment details

After screening eligible and consenting to participate, 67 participants either later changed their mind and declined to participate prior to starting data collection, were unreachable for baseline collection, or did not complete baseline in order to be randomized.

Participants by arm

ArmCount
CareAvenue (Intervention)
Participants receive access to CareAvenue, an e-health tool, and receive one weekly automated telephone call and 4-5 text messages per week for 52 weeks. CareAvenue: CareAvenue is an e-health tool providing information about diabetes management and low-cost resources. Participants in this group have access to CareAvenue and receive a weekly automated phone call and text messages related to CareAvenue and its resources as well as diabetes management.
301
Guest Assistance Program (Control)
Participants receive information about the Guest Assistance Program (GAP) and receive 3-4 text messages per week related to diabetes management and resources for 52 weeks. Guest Assistance Program: The Guest Assistance Program (GAP) is a resource, which provides assistance with medical and non-medical needs and resources to patients receiving medical care at University of Michigan health system. Participants in this group are provided with GAP information and receive text messages related to diabetes management.
299
Total600

Baseline characteristics

CharacteristicCareAvenue (Intervention)TotalGuest Assistance Program (Control)
Age, Continuous52.64 years
STANDARD_DEVIATION 13.68
53.45 years
STANDARD_DEVIATION 1304
54.26 years
STANDARD_DEVIATION 12.33
Health Insurance Type
Medicaid
45 Participants79 Participants34 Participants
Health Insurance Type
Medicare
19 Participants44 Participants25 Participants
Health Insurance Type
Medicare + Medicaid Supplemental
34 Participants64 Participants30 Participants
Health Insurance Type
Medicare + Private Supplemental
68 Participants140 Participants72 Participants
Health Insurance Type
None
2 Participants11 Participants9 Participants
Health Insurance Type
Other
1 Participants2 Participants1 Participants
Health Insurance Type
Private
132 Participants260 Participants128 Participants
Income as percent of poverty level
100-200%
52 Participants95 Participants43 Participants
Income as percent of poverty level
201-400%
131 Participants261 Participants130 Participants
Income as percent of poverty level
Greater than 400%
79 Participants164 Participants85 Participants
Income as percent of poverty level
Less than 100%
35 Participants73 Participants38 Participants
Number of chronic conditions4.12 number of chronic conditions
STANDARD_DEVIATION 2.31
4.15 number of chronic conditions
STANDARD_DEVIATION 2.31
4.18 number of chronic conditions
STANDARD_DEVIATION 2.31
Race/Ethnicity, Customized
Race
Asian
9 Participants23 Participants14 Participants
Race/Ethnicity, Customized
Race
Hispanic
16 Participants31 Participants15 Participants
Race/Ethnicity, Customized
Race
Multiple Race
22 Participants42 Participants20 Participants
Race/Ethnicity, Customized
Race
Non-Hispanic Black
43 Participants101 Participants58 Participants
Race/Ethnicity, Customized
Race
Non-Hispanic White
204 Participants388 Participants184 Participants
Race/Ethnicity, Customized
Race
Other
6 Participants13 Participants7 Participants
Region of Enrollment
United States
301 Participants600 Participants299 Participants
Sex/Gender, Customized
Gender
Female
168 Participants334 Participants166 Participants
Sex/Gender, Customized
Gender
Male
132 Participants264 Participants132 Participants
Sex/Gender, Customized
Gender
Other
1 Participants2 Participants1 Participants
Type of diabetes
Type 1
61 Participants130 Participants69 Participants
Type of diabetes
Type 2
240 Participants470 Participants230 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 3012 / 299
other
Total, other adverse events
75 / 30186 / 299
serious
Total, serious adverse events
123 / 301125 / 299

Outcome results

Primary

Change in HbA1c as Measured by an HbA1c Machine

HbA1c will be measured at baseline, 6 months, and 12 months using HbA1c machine. HbA1c is a measure of the average level of glucose in blood over the past 3 months measured as a percentage. The change in HbA1c from baseline to 12 months is reported here as the primary outcome.

Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)

Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness, unable to obtain measurement, etc.

ArmMeasureValue (MEAN)Dispersion
CareAvenue (Intervention)Change in HbA1c as Measured by an HbA1c Machine0.07 percentage of average glucose 3 monthsStandard Deviation 1.57
Guest Assistance Program (Control)Change in HbA1c as Measured by an HbA1c Machine-0.10 percentage of average glucose 3 monthsStandard Deviation 1.42
Secondary

Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Diabetes as Measured by Participant Questionnaire

Cost-Related Non-Adherence (CRN) Behaviors related to diabetes will be measured at baseline, 6 months, and 12 months by 4-items adapted from the Medicare Current Beneficiary Survey and 2 items adapted from the National Health Interview Survey that look at diabetes. The items are measured with a 4-point Likert scale. Participants answering often or sometimes to any of the items are indicated as exhibiting CRN. Min value of 0, max value of 18, with higher scores indicating more cost-related non-adherence behaviors. The change in CRN behaviors from baseline to 12 months is reported here as the secondary outcome.

Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)

Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness

ArmMeasureValue (MEAN)Dispersion
CareAvenue (Intervention)Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Diabetes as Measured by Participant Questionnaire-0.45 score on a scaleStandard Deviation 3.52
Guest Assistance Program (Control)Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Diabetes as Measured by Participant Questionnaire-0.91 score on a scaleStandard Deviation 3.62
Secondary

Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Other Conditions Being Managed as Measured by Participant Questionnaire

Cost-Related Non-Adherence (CRN) Behaviors related to other conditions being managed will be measured at baseline, 6 months, and 12 months by 4-items adapted from the Medicare Current Beneficiary Survey and 2 items adapted from the National Health Interview Survey that look at other health conditions being managed. The items are measured with a 4-point Likert scale. Participants answering often or sometimes to any of the items are indicated as exhibiting CRN. Mean values were obtained, with min value of 0, max value of 1, with higher mean scores indicating more cost-related non-adherence behaviors. The change in CRN behaviors from baseline to 12 months is reported here as the secondary outcome.

Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)

Population: Change from baseline to 12-month follow-up

ArmMeasureValue (MEAN)Dispersion
CareAvenue (Intervention)Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Other Conditions Being Managed as Measured by Participant Questionnaire-0.07 score on a scaleStandard Deviation 0.45
Guest Assistance Program (Control)Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Other Conditions Being Managed as Measured by Participant Questionnaire-0.06 score on a scaleStandard Deviation 0.48
Secondary

Change in Perceived Financial Burden as Measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT)

Perceived Financial Burden will be measured at baseline, 6 months, and 12 months by the 11-item measure Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT) that were measured on a 5-point scale (0: not at all - 4: very much). The score includes reverse-coding 6-items, summing all items, multiplying sum by 11 and dividing the total by number of items answered. Lower scores indicate higher perceptions of financial burden. (Min value of 0, max value of 44) The change in perceived financial burden (COST measure) from baseline to 12 months is reported here as secondary outcome.

Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)

Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness

ArmMeasureValue (MEAN)Dispersion
CareAvenue (Intervention)Change in Perceived Financial Burden as Measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT)2.01 score on a scaleStandard Deviation 7.47
Guest Assistance Program (Control)Change in Perceived Financial Burden as Measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT)2.74 score on a scaleStandard Deviation 7.36
Secondary

Change in Systolic Blood Pressure as Measured an Automated Blood Pressure Machine

Systolic blood pressure will be measured at baseline, 6 months, and 12 months using an automated blood pressure machine in millimeters of mercury (e.g., 120 mm Hg). The change in systolic blood pressure from baseline to 12 months is reported here as secondary outcome.

Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)

Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness, unable to obtain measurement, etc.

ArmMeasureValue (MEAN)Dispersion
CareAvenue (Intervention)Change in Systolic Blood Pressure as Measured an Automated Blood Pressure Machine-4.00 mmHgStandard Deviation 18.83
Guest Assistance Program (Control)Change in Systolic Blood Pressure as Measured an Automated Blood Pressure Machine-6.00 mmHgStandard Deviation 19.92
Secondary

Change in Unmet Social Risk Factors as Measured by 20 Items in Participant Questionnaire

Change in Unmet Social Risk Factors will be measured at baseline, 6 months, and 12 months by 20 items adapted from the Accountable Health Communities Health-Related Social Needs Screening Tool, the Health Leads Social Needs Screening Toolkit, and the Kaiser Permanente Your Current Life Situation Questionnaire. The item values are binary (yes/no). Higher number of yes responses indicates higher number of unmet social risk factors/higher need. (Min value of 0, max value of 20). The change in unmet social risk factors from baseline to 12 months is reported here as secondary outcome.

Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)

Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness

ArmMeasureValue (MEAN)Dispersion
CareAvenue (Intervention)Change in Unmet Social Risk Factors as Measured by 20 Items in Participant Questionnaire-1.05 yes responsesStandard Deviation 3.69
Guest Assistance Program (Control)Change in Unmet Social Risk Factors as Measured by 20 Items in Participant Questionnaire-1.48 yes responsesStandard Deviation 4.1
Secondary

Change in Unmet Social Risk Factors as Measured by Participant Questionnaire

Change in Unmet Social Risk Factors will be measured at baseline, 6 months, and 12 months by 3 items from the Accountable Health Communities Health-Related Social Needs Screening Tool and 1 item adapted from the National Health Interview Survey. The items each have three response options, in which a positive response indicates an unmet social risk factor. Higher scores indicate more unmet social risk factors (min value of 0; max value of 8). The change in unmet social risk factors from baseline to 12 months is reported here as secondary outcome.

Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)

Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness

ArmMeasureValue (MEAN)Dispersion
CareAvenue (Intervention)Change in Unmet Social Risk Factors as Measured by Participant Questionnaire-0.26 units on a scaleStandard Deviation 1.42
Guest Assistance Program (Control)Change in Unmet Social Risk Factors as Measured by Participant Questionnaire-0.27 units on a scaleStandard Deviation 1.38

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026